Ethyl 2-(bromomethyl)-1,3-oxazole-4-carboxylate → (+/-)-2-[[5-(2-Ethyl-7-methyl-4H-benzo[5,6]cyclohepta[1,2-d]oxazol-4-yl)-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-oxazolecarboxylic acid, ethyl ester

Beteiligte Stoffe

Rolle	Name	HCID	Einwaage
Edukt	Ethyl 2-(bromomethyl)-1,3-oxazole-4-carboxylate	HCID 641223	—
Edukt	(+/-)-5-(2-Ethyl-7-methyl-4H-benzo[5,6]cyclohepta[1,2-d]oxazol-4-yl)-2,4(1H,3H)-pyrimidinedione	HCID 70112980	—
Produkt	(+/-)-2-[[5-(2-Ethyl-7-methyl-4H-benzo[5,6]cyclohepta[1,2-d]oxazol-4-yl)-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-oxazolecarboxylic acid, ethyl ester	HCID 131722501	—

Reaktionsschritte

The subtitle compound was prepared from the product from example 1 step (vii) (6.5 g) and 2-[bromomethyl]-4-oxazolecarboxylic acid ethyl ester (Coll. Czech Chem. Comm., 1967, 32, 2155) (1.69 g) by the method of example 1 step (viii). Purification was by chromatography eluting with 60-66% ethyl acetate in toluene.

Herkunft & Nachweise

DOI	10.6084/m9.figshare.5104873.v1
Patentnummer	US06218376B1
Quelldatensatz	uspto-grants-2001_04
ORD ID	ord-b60c5104cf494f52bcd926f4682ea92e
Quellennotiz	uspto-grants-2001_04